CClinicalTrials.gg
CompletedNCT07601542Updated May 22, 2026

"Ultrasound vs. Landmark Technique for Spinal Anesthesia in Obese Women Undergoing Cesarean Section"

An interventional study of Landmark-Guided Spinal Anesthesia and Ultrasound-Assisted Spinal Anesthesia in Cesarean Section, Obese Parturient and Ultrasound Guided Subarachnoid Block, sponsored by Bangladesh Medical University. Completed at 1 site in Bangladesh. Open to female participants. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Bangladesh Medical University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Feb 2025, registered May 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Sex
Female
01

Study summary

The goal of this clinical trial is to evaluate whether the ultrasound-assisted technique improves the accuracy and safety of spinal anesthesia compared to the traditional landmark technique in obese women undergoing a cesarean section. The main questions it aims to answer are:

Does the ultrasound-assisted technique reduce the number of needle attempts required for successful spinal anesthesia? Does the ultrasound-assisted technique decrease the incidence of post-dural puncture headache (PDPH) and chronic low back pain at the needle insertion site? Does the ultrasound-assisted technique reduce procedure time compared to the landmark technique?

Participants will:

Receive spinal anesthesia using either the ultrasound-assisted technique or the traditional landmark technique for cesarean section.

Be monitored for the number of needle attempts, procedure time, and any post-operative complications such as PDPH or low back pain.

Follow up for three months after the procedure to assess any long-term effects, including chronic low back pain and quality of life.

Read the detailed description

This clinical trial is designed to compare two techniques for performing subarachnoid block (SAB) in obese women undergoing elective cesarean sections. The study aims to evaluate the effectiveness and safety of ultrasound-assisted spinal anesthesia versus the traditional landmark-guided technique. Both techniques are commonly used for regional anesthesia, but the effectiveness of ultrasound assistance in improving procedural accuracy, reducing complications, and enhancing the overall success rate in obese parturient has not been sufficiently studied.

Study Design

This is a randomized controlled trial conducted at the Obstetric Operating Theatre of Bangladesh Medical University (BMU). Participants will be randomly assigned to one of two groups: Group A (landmark technique) and Group B (ultrasound-assisted technique). The study will evaluate the following:

Primary Objective:

To assess the number of needle attempts required for successful subarachnoid block in both groups.

Secondary Objectives:

To evaluate the procedure time, incidence of post-dural puncture headache (PDPH), chronic low back pain at the needle insertion site, and quality of life related to pain.

Interventions

Both groups will receive the same local anesthetic agents for the SAB: 0.5% hyperbaric bupivacaine with 25 μg fentanyl. The techniques will differ in how the intervertebral space is located.

Group A (Landmark Technique): In this technique, the L3-L4 or L4-L5 intervertebral spaces will be identified using the traditional landmark method. The anesthesiologist will palpate the iliac crests to find Tuffier's line and will estimate the intervertebral space based on these bony landmarks.

Group B (Ultrasound-Assisted Technique): In this group, ultrasound guidance will be used to locate the intervertebral space. A low-frequency (2-5 MHz) curvilinear probe will be employed to visualize the lumbar spine. The procedure will include scanning the area to identify the midline, the interlaminar spaces, and the depth of the epidural and spinal spaces, ensuring that the correct intervertebral level is identified before needle insertion.

Randomization

Participants will be randomly assigned to one of the two intervention groups using Block randomization schedule. This will ensure that both groups are comparable at baseline and that the results are unbiased.

Procedure

Before the procedure, participants will undergo routine preoperative assessment, including fasting for 6 hours, intravenous line establishment, and monitoring. They will be positioned in a sitting position with a pillow for lumbar flexion. After preparing the skin with aseptic techniques, the spinal needle will be inserted according to the assigned technique.

In Group A, after identifying the L3-L4 or L4-L5 intervertebral space using the landmark technique, the anesthesiologist will administer the Subarachnoid Block (SAB). In Group B, ultrasound will be used to precisely identify the lumbar intervertebral spaces before needle insertion.

Follow-Up

Participants will be monitored for immediate postoperative complications, including Postdural puncture headache (PDPH), and will be assessed for chronic low back pain at the needle insertion after 3 months over phone. Additionally, the quality of life related to low back pain will be evaluated via phone interviews.

Expected Outcomes

The primary hypothesis is that the ultrasound-assisted technique will result in fewer needle attempts and a more accurate identification of the intervertebral space compared to the traditional landmark technique. Additionally, investigators expect to find that ultrasound assistance reduces the incidence of Postdural puncture headache (PDPH) and chronic low back pain, thereby improving the patient's overall quality of life postoperatively.

This trial will provide valuable insights into the effectiveness of ultrasound in improving the safety and accuracy of Subarachnoid Block (SAB) in obese parturient, potentially changing the standard of care in obstetric anesthesia for this patient population.

02

Conditions studied

  • Cesarean Section
  • Obese Parturient
  • Ultrasound Guided Subarachnoid Block

Keywords

  • Obese parturient
  • Cesarean Section
  • Subarachnoid block
03

In context

Lead sponsor

Bangladesh Medical University is the lead sponsor of 40 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Elective caesarean section
  • ASA physical status: Ⅱ
  • Obese parturient (BMI ≥ 30.1 kg/m²)

Exclusion criteria

Exclusion Criteria:

  • Allergic to local anaesthetic (0.5% Bupivacaine hydrochloride with 8% Dextrose and 2 % Lidocaine hydrochloride USP)
  • Preexisting neurological deficit by clinical examination
  • Any contraindication to SAB
  • History of scoliosis or spinal instrumentation
  • Allergy to ultrasound transmission gel
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Group A: Landmark-Guided Spinal Anesthesia

    In this arm, participants will receive subarachnoid block using the traditional landmark technique for spinal anesthesia. The L3-L4 or L4-L5 intervertebral space will be identified by palpating the iliac crests to locate Tuffier's line, and the spinal needle will be inserted based on these bony landmarks. The anesthetic agents administered will be 0.5% hyperbaric bupivacaine (10 mg) and 25 μg fentanyl (0.5 mL). The procedure will be performed by experienced anesthesiologists.

    Procedure: Landmark-Guided Spinal Anesthesia

  • Experimental
    Group B: Ultrasound-Assisted Spinal Anesthesia

    In this arm, participants will receive subarachnoid block using the ultrasound-assisted technique. A low-frequency (2-5 MHz) curvilinear probe will be used to visualize the lumbar spine and identify the intervertebral space. The correct intervertebral space (L3-L4 or L4-L5) will be identified using real-time ultrasound imaging. The anesthetic agents administered will be 0.5% hyperbaric bupivacaine (10 mg) and 25 μg fentanyl (0.5 mL). This procedure will also be performed by experienced anesthesiologists with expertise in neuraxial ultrasound.

    Procedure: Ultrasound-Assisted Spinal Anesthesia

Interventions

  • ProcedureLandmark-Guided Spinal Anesthesia

    This intervention involves the use of traditional anatomical landmarks to locate the correct intervertebral space for performing subarachnoid block (SAB). The anesthesiologist identifies the L3-L4 or L4-L5 intervertebral space by palpating the iliac crests and using Tuffier's line as a reference. A 25G Quincke needle is used for SAB, and 0.5% hyperbaric bupivacaine with 25 μg fentanyl is administered. This technique is the standard approach used in many clinical settings for spinal anesthesia.

  • ProcedureUltrasound-Assisted Spinal Anesthesia

    This intervention utilizes ultrasound guidance to identify the correct intervertebral space for performing subarachnoid block (SAB). A low-frequency (2-5 MHz) curvilinear ultrasound probe is used to visualize the lumbar spine in real-time, ensuring precise identification of the L3-L4 or L4-L5 intervertebral space. The anesthesiologist places the needle based on ultrasound images that show the anatomical structures, such as the spinous processes and interlaminar spaces. The same anesthetic agents (0.5% hyperbaric bupivacaine and 25 μg fentanyl) are administered through a 25G Quincke needle for SAB.

06

What researchers measure

Primary outcomes

  1. Number of Needle Attempts for Successful Subarachnoid Block

    his is the key measure in your study, as it directly assesses the effectiveness of the two anesthesia techniques (ultrasound-assisted vs. landmark-guided) in achieving successful spinal anesthesia. Fewer needle attempts would indicate a higher success rate and a more efficient technique, making it the most critical outcome for evaluating the interventions.

    Time frame: During the procedure, until successful spinal needle placement

Secondary outcomes

  1. Needle Insertion Site Accuracy in landmark technique group

    This measure evaluates whether the correct intervertebral space was identified and the needle was inserted at the intended location. Accuracy will be assessed using ultrasound imaging in the recovery room to verify the spinal leve

    Time frame: Immediately after transferring the participants in the recovery room

  2. Procedure Duration in minutes

    This outcome will assess the time taken to perform the spinal anesthesia procedure from the beginning of patient positioning for spinal anaesthesia to the successful Spinal Needle insertion.

    Time frame: During procedure

  3. Incidence of Post-Dural Puncture Headache (PDPH)

    The incidence of PDPH will be recorded in the immediate postoperative period. Participants will be monitored for symptoms such as headache, nausea, and neck stiffness, which are common after dural puncture.

    Time frame: Postoperative period (up to 72 hours)

  4. Chronic Low Back Pain at Needle Insertion Site

    Chronic low back pain at the needle insertion site will be evaluated via phone follow-up using the Numerical Rating Scale (NRS) to assess pain intensity. The impact on daily activities, including work, sleep disturbances, and mobility, will also be documented

    Time frame: 3 months post-procedure

  5. Impact of Chronic Low Back Pain on Quality of Life

    Quality of life is assessed using the 12-Item Short Form Health Survey (SF-12), a validated, widely used questionnaire measuring health-related quality of life across two domains: Physical Component Summary (PCS): captures physical functioning, bodily pain, and general physical health. Mental Component Summary (MCS): captures emotional well-being, social functioning, vitality, and mental health. Responses are collected via phone interview by trained study staff. Data are coded according to Short-Form-12 (SF-12) guidelines and aggregated into summary scores. Score Range: 0-100, with higher scores indicating better quality of life (less limitation or distress).

    Time frame: 3 months post-procedure

07

Study locations

1 site
  • Bangladesh Medical University
    Dhaka, 1000, Bangladesh
08

References and documents

Publications

  • Wattanaruangkowit P, Lakchayapakorn K. The position of the lumbar vertebrae in relation to the intercrestal line. J Med Assoc Thai. 2010 Nov;93(11):1294-300. PubMed 21114209 ↗
  • Srinivasan KK, Leo AM, Iohom G, Loughnane F, Lee PJ. Pre-procedure ultrasound-guided paramedian spinal anaesthesia at L5-S1: Is this better than landmark-guided midline approach? A randomised controlled trial. Indian J Anaesth. 2018 Jan;62(1):53-60. doi: 10.4103/ija.IJA_448_17. PubMed 29416151 ↗
  • Sahin T, Balaban O, Sahin L, Solak M, Toker K. A randomized controlled trial of preinsertion ultrasound guidance for spinal anaesthesia in pregnancy: outcomes among obese and lean parturients: ultrasound for spinal anesthesia in pregnancy. J Anesth. 2014 Jun;28(3):413-9. doi: 10.1007/s00540-013-1726-1. Epub 2013 Oct 20. PubMed 24141882 ↗
  • Kurdi MS, Agrawal P, Thakkar P, Arora D, Barde SM, Eswaran K. Recent advancements in regional anaesthesia. Indian J Anaesth. 2023 Jan;67(1):63-70. doi: 10.4103/ija.ija_1021_22. Epub 2023 Jan 21. PubMed 36970484 ↗
  • Khan MA, Gupta M, Sharma S, Kasaudhan S. A comparative study of ultrasound assisted versus landmark technique for combined spinal-epidural anaesthesia in patients undergoing lower limb orthopaedic surgery. Indian J Anaesth. 2022 Apr;66(4):272-277. doi: 10.4103/ija.ija_775_21. Epub 2022 Apr 20. PubMed 35663223 ↗
  • Gayathri B, Swetha Ramani CK, Urkavalan K, Pushparani A, Rajendran A. Comparison of the time taken for subarachnoid block using ultrasound-guided method versus landmark technique for cesarean section - A randomized controlled study. J Anaesthesiol Clin Pharmacol. 2021 Apr-Jun;37(2):205-209. doi: 10.4103/joacp.JOACP_35_20. Epub 2021 Jul 15. PubMed 34349367 ↗
  • Forozeshfard M, Jahan E, Amirsadat J, Ghorbani R. Incidence and Factors Contributing to Low Back Pain in the Nonobstetrical Patients Operated Under Spinal Anesthesia: A Prospective 1-Year Follow-Up Study. J Perianesth Nurs. 2020 Feb;35(1):34-37. doi: 10.1016/j.jopan.2019.06.008. Epub 2019 Oct 18. PubMed 31635919 ↗
  • Bhardwaj D, Thakur L, Sharma S, Rana S, Gupta B, Sharma C. Comparative evaluation of three techniques for paramedian subarachnoid block: Point-of-care preprocedural ultrasound assisted, real-time ultrasound guided and landmark based. Indian J Anaesth. 2022 Mar;66(Suppl 2):S102-S107. doi: 10.4103/ija.ija_373_21. Epub 2022 Mar 25. PubMed 35601040 ↗
  • Betran AP, Ye J, Moller AB, Zhang J, Gulmezoglu AM, Torloni MR. The Increasing Trend in Caesarean Section Rates: Global, Regional and National Estimates: 1990-2014. PLoS One. 2016 Feb 5;11(2):e0148343. doi: 10.1371/journal.pone.0148343. eCollection 2016. PubMed 26849801 ↗
  • Bajwa SJ, Bajwa SK. Anaesthetic challenges and management during pregnancy: Strategies revisited. Anesth Essays Res. 2013 May-Aug;7(2):160-7. doi: 10.4103/0259-1162.118945. PubMed 25885826 ↗
  • At A, So O. Failed spinal anaesthesia for caesarean section. J West Afr Coll Surg. 2011 Oct;1(4):1-17. PubMed 25452968 ↗
  • Ansari T, Yousef A, El Gamassy A, Fayez M. Ultrasound-guided spinal anaesthesia in obstetrics: is there an advantage over the landmark technique in patients with easily palpable spines? Int J Obstet Anesth. 2014 Aug;23(3):213-6. doi: 10.1016/j.ijoa.2014.03.001. Epub 2014 Mar 12. PubMed 24768303 ↗

Related links

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07601542
Lead sponsor
Bangladesh Medical University
Responsible party
Kazi Mahzabin Arin (Assistant Professor, Bangladesh Medical University) — Principal investigator
First posted
May 22, 2026
Start date
Feb 1, 2025
Primary completion
Aug 30, 2025
Completion
Nov 30, 2025
Last update
May 22, 2026

Study contacts

AKM Akhtaruzzaman, MD
study director · Bangladesh Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion